|
|
The value of circulating blood ANRIL in the early diagnosis of acute myocardial infarction |
HUANG Ying ZHANG Yun NONG Wenzheng LAN Biyang PAN Rubao ZHANG Dingmin |
Department of Cardiovascular, Affiliated Ethnic Hospital of Guangxi Medical University, Guangxi Zhuang Autonomous Region, Nanning 530001, China |
|
|
Abstract Objective To investigate the value of circulating ANRIL in the early diagnosis of acute myocardial infarction (AMI). Methods Blood samples were collected from 50 AMI patients (experimental group) and 30 patients with coronary angiography normally (control group) from November 2016 to June 2018 in Affiliated Ethnic Hospital of Guangxi Medical University (hereinafter referred to as “our hospital”). Quantitative real-time fluorescence polymerase chain reaction (qRT-PCR) was used to detect the levels of circulating ANRIL at different time intervals (0-6 h, 12 h, 24 h, 7 d and 14 d) after the onset of symptoms of AMI. And the level of plasma cTnT was detected by using electrochemiluminescence. Results There was no significant difference in age, gender, smoking, diabetes, LDL-C, SBP, DBP and Cr between two groups (P > 0.05). There was significant difference in cTnT between two groups (P < 0.05). Compared with control group, the expression level of ANRIL and cTnT in the plasma of AMI patients increased significantly (P < 0.05). In experimental group, the expression level of ANRIL began to increase at the time of admission, decreased after reaching the peak at 12 h, and decreased to the normal range at 7 d. CTnT had a very long diagnostic window period, it started to rise significantly at 6-12 h, then decreased at 24 h, and falled to the normal range at 14 d. ROC analysis showed that when the expression value of ANRIL in 6 h was 3.65 times (the highest value) of the normal control, the sensitivity was 91.9%, the specificity was 91.1%, which was the best diagnostic node; when the cTnT value increased to the highest value of 24 h, the sensitivity and specificity of AMI diagnosis was 91.8%, 92.4% respectively. Conclusion The expression of circulating ANRIL in AMI patients increases significantly and changes dynamically with the course of disease. Compared with cTnT, circulating ANRIL has earlier time window and peak time. It has good early sensitivity and specificity for the diagnosis of AMI.
|
|
|
|
|
[1] White HD,Chew DP. Acute myocardial infarction [J]. Lancet,2008,372(9638):570-584.
[2] Adler C,Baldus S. Troponin elevation—does every patient require coronary angiography? [J]. Med Klin Intensivmed Notfmed,2019.[Epub ahead of print]
[3] 张骏,田华伟.阿司匹林联合替格瑞洛对急性心肌梗死患者不良心脏事件的影响[J].中国现代医生,2018,56(24):40-43.
[4] 姚锴,余桂霞,曾仙梅.急性心肌梗死患者住院期间近期转归的影响因素分析[J].河北医学,2019,25(7):1217-1221.
[5] Antman EM,Hand M,Armstrong PW,et al. 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines:developed in collaboration with the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians:2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients with ST-Elevation Myocardial Infarction,Writing on Behalf of the 2004 Writing Committee [J]. Circulation,2008,117(2):296-329.
[6] 陈峰,庞继恩,孙强,等.急性心肌梗死患者血清高敏肌钙蛋白T及线粒体偶联因子-6含量的变化[J].中国循证心血管医学杂志,2012,4(5):431-433.
[7] van Rooij E,Liu N,Olson EN. MicroRNAs flex their muscles [J]. Trends Genet,2008,24(4):159-166.
[8] Harismendy O,Notani D,Song X,et al. 9p21 DNA variants associated with coronary artery disease impair interferon-gamma signalling response [J]. Nature,2011,470(7333):264-268.
[9] Folkersen L,Kyriakou T,Goel A,et al. Relationship between CAD risk genotype in the chromosome 9p21 locus and gene expression. Identification of eight new ANRIL splice variants [J]. PLoS One,2009,4(11):e7677.
[10] Broadbent HM,Peden JF,Lorkowski S,et al. Susceptibility to coronary artery disease and diabetes is encoded by distinct,tightly linked SNPs in the ANRIL locus on chromosome 9p [J]. Hum Mol Genet,2008,17(6):806-814.
[11] Thygesen K,Alpert JS,Jaffe AS,et al. Third universal definition of myocardial infarction [J]. Glob Heart,2012, 7(4):275-295.
[12] Agewall S,Giannitsis E,Jernberg T,et al. Troponin elevation in coronary vs. non-coronary disease [J]. Eur Heart J,2011,32(4):404-411.
[13] Cao WJ,Wu HL,He BS,et al. Analysis of long non-coding RNA expression profiles in gastric cancer [J]. World J Gastroenterol,2013,19(23):3658-3664.
[14] Wang S,Zhang X,Yuan Y,et al. BRG1 expression is increased in thoracic aortic aneurysms and regulates proliferation and apoptosis of vascular smooth muscle cells through the long non-coding RNA HIF1A-AS1 in vitro [J]. Eur J Cardiothorac Surg,2015,47(3):439-446.
[15] Kumarswamy R,Bauters C,Volkmann I,et al. Circulating long noncoding RNA,LIPCAR,predicts survival in patients with heart failure [J]. Circ Res,2014,114(10):1569-1575.
[16] Vausort M,Wagner DR,Devaux Y. Long noncoding RNAs in patients with acute myocardial infarction [J]. Circ Res,2014,115(7):668-677.
[17] Hung J,Miscianinov V,Sluimer JC,et al. Targeting non-coding RNA in vascular biology and disease [J]. Front Physiol,2018,9(22):1655.
[18] Kumar S,Williams D,Sur S,et al. Role of flow-sensitive microRNAs and long noncoding RNAs in vascular dysfunction and atherosclerosis [J]. Vascul Pharmacol,2019, 114:76-92.
[19] Johnson AD,Hwang SJ,Voorman A,et al. Resequencing and clinical associations of the 9p21.3 region:a comprehensive investigation in the Framingham heart study [J]. Circulation,2013,127(7):799-810.
[20] Zhang L,Wang YM. Expression and function of lncRNA ANRIL in a mouse model of acute myocardial infarction combined with type 2 diabetes mellitus [J]. J Chin Med Assoc,2019,9(82):685-692. |
|
|
|